Short answer
AVITA Medical, Inc. (RCEL) filed its Q1 2026 10-Q quarterly report on May 14, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $19M (up 4.0% year over year) with net income of −$11M.
Q1 2026 key financials · XBRL
- Revenue
- $19M
- +4.0% YoY
- Net income
- −$11M
- +23.4% YoY
- Operating margin
- -45.7%
- Gross margin
- 81.7%
- EPS (diluted)
- −$0.35
- +34.0% YoY
Source: XBRL data from the AVITA Medical, Inc. (RCEL) Q1 2026 10-Q on SEC EDGAR. USD.
AVITA Medical, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes from the 2025 Annual Report
- Carried-forward risks could materially adversely affect liquidity and capital position
- Carried-forward risks could cause actual results to differ materially from forward-looking statements
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other AVITA Medical, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.